KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $1.6B
- YoY, 2025
- +89.0%
- 5-year CAGR
- +41.0%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $1.6B | +89.0% |
| 2024 | $836M | +111.6% |
| 2023 | $395M | −19.4% |
| 2022 | $490M | +6.6% |
| 2021 | $460M | +61.9% |
| 2020 | $284M | — |
| 2019 | −$74M | — |